Equifax (EFX) Stock Jumps 14.9%: Will It Continue to Soar?

EFX

Equifax (EFX - Free Report) shares ended the last trading session 14.9% higher at $221.41. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.5% gain over the past four weeks.

The stock scored this price increase in response to the company’s better-than-expected first-quarter 2021 results. Adjusted earnings of $1.97 per share beat the Zacks Consensus Estimate by 29.6% and improved on a year-over-year basis. Earnings exceeded the guided range of $1.45-$1.55. Revenues of $1.21 billion outpaced the consensus estimate by 7.9% and increased 26.6% year over year. The reported figure exceeded the guided range of $1.11 -$1.13 billion.

Price and Consensus

This credit reporting company is expected to post quarterly earnings of $1.52 per share in its upcoming report, which represents a year-over-year change of -5%. Revenues are expected to be $1.07 billion, up 8.7% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For Equifax, the consensus EPS estimate for the quarter has been revised 1.6% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on EFX going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>